News

Eli Lilly’s Alzheimer’s trek; Novo Nordisk puts down US roots; Sarepta and gene therapy accelerated approvals; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full […]

News

Fresh Start Surgical Gifts Hosts 32nd Annual Celebrity Golf Classic Hosted by Alfonso Ribeiro, Transforming Lives One Swing at a Time

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Nationally recognized nonprofit, Fresh Start Surgical Gifts is teeing up for its 32nd Annual San Diego Celebrity Golf Classic, celebrating another year of transforming lives. The event will […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Avidity Biosciences Honors Rare Disease Day®

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its support for Rare […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

SAN DIEGO–(BUSINESS WIRE)–Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

ADVERTISEMENT — Advertise With Biotech Networks
News

‘Gene of Prejudice’ Demystifies Autism

Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

SAN DIEGO, Feb. 28, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, March 12, 2024, at […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2023. “2023 was a transformational year for Acadia that positioned us for continued […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium

BRIDGEWATER, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced […]

No Picture
News

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) — – Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company […]